1
|
Glimelius B, Tiret E, Cervantes A and
Arnold D: ESMO Guidelines Working Group: Rectal cancer: ESMO
clinical practice guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 24 Suppl 6:vi81–vi88. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Watanabe T, Itabashi M, Shimada Y, Tanaka
S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, et
al: Japanese Society for Cancer of the Colon and Rectum (JSCCR)
Guidelines 2014 for treatment of colorectal cancer. Int J Clin
Oncol. 20:207–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Matthiessen P, Hallböök O, Rutegård J,
Simert G and Sjödahl R: Defunctioning stoma reduces symptomatic
anastomotic leakage after low anterior resection of the rectum for
cancer: A randomized multicenter trial. Ann Surg. 246:207–214.
2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Veenhof AA, van der Peet DL, Meijerink WJ
and Cuesta MA: Defunctioning stoma reduces symptomatic anastomotic
leakage after low anterior resection of the rectum for cancer: A
randomized multicenter trial. Ann Surg. 247:718–720. 2008.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Katsuno H, Shiomi A, Ito M, Koide Y, Maeda
K, Yatsuoka T, Hase K, Komori K, Minami K, Sakamoto K, et al:
Comparison of symptomatic anastomotic leakage following
laparoscopic and open low anterior resection for rectal cancer: A
propensity score matching analysis of 1014 consecutive patients.
Surg Endosc. 30:2848–2856. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Baker ML, Williams RN and Nightingale JM:
Causes and management of a high-output stoma. Colorectal Dis.
13:191–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Villafranca JJ Arenas, López-Rodriguez C,
Abilés J, Rivera R, Gándara Adán N and Navarro P Utrilla: Protocol
for the detection and nutritional management of high-output stomas.
Nutr J. 14:452015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Rostami K and Al Dulaimi D: Elemental
diets role in treatment of high ileostomy output and other
gastrointestinal disorders. Gastroenterol Hepatol Bed Bench.
8:71–76. 2015.PubMed/NCBI
|
9
|
Newton CR: Effect of codeine phosphate,
Lomotil, and Isogel on iileostomy function. Gut. 19:377–383. 1978.
View Article : Google Scholar : PubMed/NCBI
|
10
|
King RF, Norton T and Hill GL: A
double-blind crossover study of the effect of loperamide
hydrochloride and codeine phosphate on ileostomy output. Aust N Z J
Surg. 52:121–124. 1982. View Article : Google Scholar : PubMed/NCBI
|
11
|
Artinyan A, Nunoo-Mensah JW,
Balasubramaniam S, Gauderman J, Essani R, Gonzalez-Ruiz C, Kaiser
AM and Beart RW Jr: Prolonged postoperative ileus-definition, risk
factors, and predictors after surgery. World J Surg. 32:1495–1500.
2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Gaertner WB, Madoff RD, Mellgren A, Kwaan
MR and Melton GB: Postoperative diarrhea and high ostomy output
impact postoperative outcomes after elective colon and rectal
operations regardless of Clostridium difficile infection. Am J
Surg. 210:759–765. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Greenberg DE, Jiang ZD, Steffen R,
Verenker MP and DuPont HL: Markers of inflammation in bacterial
diarrhea among travelers, with a focus on enteroaggregative
Escherichia coli pathogenicity. J Infect Dis. 185:944–949. 2002.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Neurath MF: Cytokines in inflammatory
bowel disease. Nat Rev Immunol. 14:329–342. 2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Arita M, Yoshida M, Hong S, Tjonahen E,
Glickman JN, Petasis NA, Blumberg RS and Serhan CN: Resolvin E1, an
endogenous lipid mediator derived from omega-3 eicosapentaenoic
acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced
colitis. Proc Natl Acad Sci USA. 102:7671–7676. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Konuma K, Itoh M, Suganami T, Kanai S,
Nakagawa N, Sakai T, Kawano H, Hara M, Kojima S, Izumi Y and Ogawa
Y: Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis
in a novel mouse model using melanocortin 4 receptor-deficient
mice. PLoS One. 10:e01215282015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Read JA, Beale PJ, Volker DH, Smith N,
Childs A and Clarke SJ: Nutrition intervention using an
eicosapentaenoic acid (EPA)-containing supplement in patients with
advanced colorectal cancer. Effects on nutritional and inflammatory
status: A phase II trial. Support Care Cancer. 15:301–307. 2007.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Sánchez-Lara K, Turcott JG,
Juárez-Hernández E, Nuñez-Valencia C, Villanueva G, Guevara P, De
la Torre-Vallejo M, Mohar A and Arrieta O: Effects of an oral
nutritional supplement containing eicosapentaenoic acid on
nutritional and clinical outcomes in patients with advanced
non-small cell lung cancer: Randomised trial. Clin Nutr.
33:1017–1023. 2014. View Article : Google Scholar : PubMed/NCBI
|